Heart disease is the number one cause of death in diabetic patients.
OKC
OMRF findings pave way for better treatment options for Sjögren’s patients
The findings will allow for more targeted treatment approaches.
OMRF scientist receives $300,000 from Lupus Research Alliance
The Lupus Research Alliance is the world’s leading private funder of lupus research.
New use for OMRF brain cancer treatment could extend lives
In a new study, the OMRF compound OKN-007 is being combined with the current standard-of-care medication for glioblastoma.
OMRF scientists discover potential therapeutic target for lymphedema
Lymphedema is a disease characterized by dramatic and painful swelling in the limbs that often leads to infections.
Oklahoma teen lives with unique skeletal disorder
Sydney Rutz is one in five billion.